Clinical trial
Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Newborn With Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)
NCT02504944 is registered in ClinicalTrials.gov with Meyer Children's Hospital IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Newborn With Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)
- Lead sponsor
- Meyer Children's Hospital IRCCS
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2015
- Completion date
- August 31, 2018
- Enrollment
- 98 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.